Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Family Physician
MBBS, MCPS (Family Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, MCPS Family Medicine
Internal Medicine Specialist
MBBS, MD (Internal Medicine)
Internal Medicine Specialist
MBBS, MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
MBBS, MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Andrologist
MBBS, FCPS, EBEEDM, FECSM, Fellowship in Internal Medicine (CPSP) , European Board in Endocrinology and Diabetes (UEMS) , Fellowship in Reproductive Medicine (UEMS)
Andrologist
MBBS, FCPS, EBEEDM, FECSM, Fellowship in Internal Medicine (CPSP) , European Board in Endocrinology and Diabetes (UEMS) , Fellowship in Reproductive Medicine (UEMS)
Nephrologist
M.B.B.S., M.R.C.P (Ireland)
Consultant Physician
MBBS, MRCP (UK)
Internal Medicine Specialist
Certified in Diabetology (USA), F.C.P.S (Medicine), M.B.B.S
Internal Medicine Specialist
Certified in Diabetology (USA), F.C.P.S (Medicine), M.B.B.S
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures